1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow EMagnusson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation Campath, Daclizumab - Kidney Transplantation, Kidney Diseases | Phase 4 | Completed | EMagnusson | 123 | 2005-10-01 | 2021-09-29 |
Kidney Diseases (1) · Renal Insufficiency (1)
Alemtuzumab (1) · Daclizumab (1)
United Kingdom (1)
Adam G McLean, FRCP, DPhil (1) · David H Taube, MBBCh, FRCP (1)
2005 (1)